Oops! Something went wrong, please try again later.
2016: Abbott launches the first systems in its Alinity series, a family of diagnostics and informatics systems that represent a major leap forward in terms …
Now, as more biosimilars become available, more people will be able to access life-saving medicines sooner. Abbott is partnering with biotechnology companies to bring cutting-edge biosimilars...
Save
Share
More
